Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
American Journal of Obstetrics and Gynecology
|
August 1, 1987
Red blood cell zinc protoporphyrin testing for iron-deficiency anemia in pregnancy
R B Schifman, J E Thomasson, J M Evers
Journal of Continuing Education in Nursing
|
September 1, 1989
New directions for nurse managers
J M Evers, T Porter-O'Grady, E J George, et al.
Genetic Counseling (Geneva, Switzerland)
|
November 15, 2006
The velocardiofacial syndrome in older age: dementia and autistic features
L J M Evers, M P Vermaak, J J M Engelen, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
May 1, 1991
Temperature effects on serum prolactin concentrations and activity of dopaminergic neurons in the infundibulum/pituitary stalk of calves
H A Tucker, L T Chapin, K J Lookingland, et al.
Genetic Counseling (Geneva, Switzerland)
|
February 19, 2010
The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at adult age
L J M Evers, C E M De Die-Smulders, E E J Smeets, et al.
European Journal of Medical Genetics
|
February 28, 2016
The use of two different MLPA kits in 22q11.2 deletion syndrome
L J M Evers, J J M Engelen, L M H Houben, et al.
Psychopharmacology
|
June 10, 2015
Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome
Laurens J M Evers, Therese A M J van Amelsvoort, Jaap A Bakker, et al.
Journal of Intellectual Disability Research : JIDR
|
February 18, 2014
Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability
L J M Evers, T A M J van Amelsvoort, M J J M Candel, et al.
The International Journal of Neuropsychopharmacology
|
April 10, 2014
Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome
Laurens J M Evers, Leopold M G Curfs, Jaap A Bakker, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 4, 2019
Low prevalence of substance use in people with 22q11.2 deletion syndrome
Claudia Vingerhoets, Mathilde J F van Oudenaren, Oswald J N Bloemen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
American Journal of Obstetrics and Gynecology
|
August 1, 1987
Red blood cell zinc protoporphyrin testing for iron-deficiency anemia in pregnancy
R B Schifman, J E Thomasson, J M Evers
Journal of Continuing Education in Nursing
|
September 1, 1989
New directions for nurse managers
J M Evers, T Porter-O'Grady, E J George, et al.
Genetic Counseling (Geneva, Switzerland)
|
November 15, 2006
The velocardiofacial syndrome in older age: dementia and autistic features
L J M Evers, M P Vermaak, J J M Engelen, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
May 1, 1991
Temperature effects on serum prolactin concentrations and activity of dopaminergic neurons in the infundibulum/pituitary stalk of calves
H A Tucker, L T Chapin, K J Lookingland, et al.
Genetic Counseling (Geneva, Switzerland)
|
February 19, 2010
The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at adult age
L J M Evers, C E M De Die-Smulders, E E J Smeets, et al.
European Journal of Medical Genetics
|
February 28, 2016
The use of two different MLPA kits in 22q11.2 deletion syndrome
L J M Evers, J J M Engelen, L M H Houben, et al.
Psychopharmacology
|
June 10, 2015
Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome
Laurens J M Evers, Therese A M J van Amelsvoort, Jaap A Bakker, et al.
Journal of Intellectual Disability Research : JIDR
|
February 18, 2014
Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability
L J M Evers, T A M J van Amelsvoort, M J J M Candel, et al.
The International Journal of Neuropsychopharmacology
|
April 10, 2014
Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome
Laurens J M Evers, Leopold M G Curfs, Jaap A Bakker, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 4, 2019
Low prevalence of substance use in people with 22q11.2 deletion syndrome
Claudia Vingerhoets, Mathilde J F van Oudenaren, Oswald J N Bloemen, et al.
Page
of 1